Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
A Phase I Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Live-Attenuated Tetravalent Dengue Vaccine (V181) in Flavivirus-Naive and Flavivirus-Experienced Health Adults (MK-V181-001-01)
Rupp, Richard
(PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
1/4/18
→
1/3/21
Funding
Merck Sharp and Cohme Corporation ( Award # ):
$5,750.00
View all
View less